Aims-To investigate the pattern of telomerase activity in hydatidiform mole
as compared with normal placenta and choriocarcinoma, and to determine the
prognostic significance of telomerase activity in hydatidiform mole.
Methods-Telomerase activity in 35 cases of hydatidiform mole, 35 normal pla
centas, one choriocarcinoma sample, and two choriocarcinoma cell lines (JAR
, JEG3) was determined using the sensitive polymerase chain reaction based
telomeric repeat amplification protocol (TRAP) assay. Two cases of breast c
arcinoma and two cases of ovarian carcinoma were also included as positive
controls in the telomerase assay.
Results-Telomerase activity was detected in 11 of 30 early placentas (36.7%
), one of five term placentas (20%), five of 27 hydatidiform moles which re
gressed spontaneously (18.5%), and six of eight hydatidiform moles which de
veloped persistent trophoblastic disease (75%) (including three which devel
oped metastases). Hydatidiform moles which subsequently developed persisten
t disease, especially those which metastasised, were more likely to express
telomerase activity (p<0.01). However, there was no Significant difference
in the frequency of telomerase activity between early placentas and hydati
diform mole. Strong telomerase activity was observed in choriocarcinoma tis
sue, choriocarcinoma cell lines, and ovarian and breast carcinomas.
Conclusions Telomerase activation occurs in hydatidiform mole with a simila
r incidence to early normal placentas. This supports the concept that hydat
idiform mole is essentially an abnormal conceptus. There is an association
between telomerase activation and the development of persistent trophoblast
ic disease. Further study is warrant to confirm the prognostic significance
of telomerase activity in hydatidiform mole.